Gilbert Halley E 4

4 · Arcutis Biotherapeutics, Inc. · Filed Jun 9, 2026

AI-generated summary of this filing

Updated Jun 10, 2026

Arcutis (ARQT) Director Gilbert Halley Receives RSU/Derivative Award

What Happened

Gilbert Halley, a director of Arcutis Biotherapeutics (ARQT), was granted two awards on June 5, 2026: 5,778 restricted stock units (RSUs) and 16,667 derivative awards (total 22,445). Both awards show an acquisition price of $0.00 (no cash paid).
The RSUs convert into one share of common stock per RSU upon vesting. The 16,667 derivative award’s underlying shares (options/derivative) vest and become exercisable 100% on the earlier of the first anniversary of the grant date (June 5, 2026) or immediately before the next annual meeting, subject to continued service.

Key Details

Transaction date: 2026-06-05; reported on Form 4 filed 2026-06-09 (timely filing).
Prices: $0.00 per share for both awards (standard for grants/compensation).
Total awarded: 5,778 RSUs + 16,667 derivative units = 22,445 potential shares upon vesting/exercise.
Shares owned after transaction: Not disclosed in the filing.
Footnotes: F1 explains RSU mechanics (1 RSU = 1 share at vesting); F2 explains the derivative award vests/exercisable 100% on the stated schedule.
No indication of a 10b5-1 plan, sale, tax withholding, or cashless exercise in the filing.

Context

RSU and derivative grants to non-employee directors are common as board compensation and do not represent an immediate market purchase or sale; they convert to or allow acquisition of shares only upon vesting/exercise.
Because these are awards (not open-market purchases or sales), they are routine compensation rather than direct statements of buy/sell intent.

Form 4

Period: 2026-06-05

Director

Transactions

Award
Common Stock
[F1]
2026-06-05+5,778→ 27,901 total
Award
Stock Option (right to buy)
[F2]
2026-06-05+16,667→ 16,667 total
Exercise: $21.23Exp: 2036-06-05→ Common Stock (16,667 underlying)

Footnotes (2)

[F1]Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
[F2]The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.

Signature

/s/Latha Vairavan, as Attorney-in-Fact for Halley E. Gilbert|2026-06-09

1 file